MIRA Pharmaceuticals board approves SKNY Pharmaceuticals acquisition; combined value tops $60M
MIRA Pharmaceuticals board approves SKNY Pharmaceuticals acquisition; combined value tops $60M
MIRA Pharmaceuticals signs LOI to acquire SKNY Pharmaceuticals
MIRA dad Siqi Chen faces backlash over controversial ZERO token launch
MIRA dad vows to repay losses from rugged test token ZERO
MIRA Memecoin Sparks Interest Amidst Solana’s Active Address Decline and Broader Memecoin Trends
MIRA crypto’s 2024 journey – Is it the same as other Solana-based memecoins?
10.42MUSD
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
-
CUSIP
-
Sector
Healthcare
Industry
Drug Manufacturers - General
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
0.21
Dividend Share
-
Dividend Yield
-
Earnings Share
-0.66
Wall Street Target Price
16.50
EPS Estimate Current Year
-0.62
EPS Estimate Next Year
-0.40
EPS Estimate Current Quarter
0
EPS Estimate Next Quarter
0
Most Recent Quarter
-
Revenue TTM
0
Gross Profit TTM
0
EBITDA
-
Profit Margin
0.00%
Return On Assets TTM
-266.11%
Return On Equity TTM
-1807.80%
Revenue Per Share TTM
0
Qtly Revenue Growth YOY
0.00%
Diluted Eps TTM
-0.66
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
0
Price Sales TTM
0
Price Book MRQ
1.9306
Enterprise Value Revenue
0
Enterprise Value EBITDA
-1
195.00
3.17%761.02
2.95%74.25
1.59%79.39
1.53%167.19
1.49%115.00
1.20%147.50
0.07%333.33
-4.16%38.84
-0.18%316.57
-0.07%